Business Context and Reporting Period
Creative Medical Technology Holdings, Inc. filed this Form 8-K on November 2, 2016, to report a material event under Item 8.01 (Other Events). The Company is incorporated in Nevada and maintains its principal executive offices in Phoenix, Arizona.
Key Financial Metrics
This filing is a current report regarding a corporate event and does not contain financial statements. Consequently, the filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The primary material event disclosed is the execution of a license agreement on November 2, 2016. Under this agreement, the Company obtained the right to use multipotent amniotic fetal stem cells licensed from the University of California, San Diego.
Guidance, Outlook, and Risks
The press release furnished as Exhibit 99.1 contains forward-looking statements based on information available as of the report date. Management warns that actual results could differ materially from anticipated outcomes due to various factors, including those discussed in the Company's Annual Report on Form 10-K for the year ended December 31, 2015. The Company assumes no obligation to update these forward-looking statements.
Investor Verification Checklist
- Verify the specific terms and financial obligations of the license agreement with the University of California, San Diego by reviewing Exhibit 99.1.
- Review the Company's most recent Form 10-K (year ended December 31, 2015) for detailed risk factors and historical financial performance.
- Confirm the regulatory status and development timeline of the multipotent amniotic fetal stem cells.
- Assess the Company's current cash position and ability to fund the commercialization of the licensed technology, as this 8-K does not disclose current liquidity.